SCHEMBL5156789

SCHEMBL5156789

CC(C)(C)ON(C=O)CCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1467658 0.88 TDP1 (0.31)
SCHEMBL4818147 0.86 TDP1 (0.33)
SCHEMBL6676603 0.84 TDP1 (0.36)
SCHEMBL29000774 0.84 TDP1 (0.36)
SCHEMBL7672790 0.83 TSHR (0.36)
SCHEMBL3327598 0.82 TDP1 (0.31)
SCHEMBL4203974 0.80
SCHEMBL9563418 0.78
SCHEMBL21293786 0.78
SCHEMBL567668 0.78 TDP1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6329338-B1 CYCLIC OLIGOPEPTIDE TETRAESTES MEIJI SEIKA KAISHA, LTD. (JP) 2001-12-11 US claimed
EP-0903347-A1 NOVEL CYCLIC DEPSIPEPTIDE PF1022 DERIVATIVES MEIJI SEIKA KAISHA LTD. (JP) 1999-03-24 EP claimed
CN-103073726-B Segmented copolymer and liquid composition and nucleic acid preparation and its preparation method and application SHENZHEN RIBO BIOTECHNOLOGY CO., LTD. (CN) 2015-09-23 CN disclosed
US-20070054909-A1 VLA-4 inhibitor compounds DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-03-08 US disclosed
US-7179819-B2 VLA-4 inhibitor compounds DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-02-20 US disclosed
US-6831175-B2 Such as N,N-dimethyl-N-(2-((5-((E)-2-pyridin-4-ylvinyl) pyridin-3-yl)oxy)ethyl)amine ABBOTT LABORATORIES 2004-12-14 US disclosed
US-20040229858-A1 VLA-4 inhibitor compounds DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2004-11-18 US disclosed
EP-1463505-A2 3-(PHENYL-ALKOXY)-5-(PHENYL)-PYRIDINE DERIVATIVES AND RELATED COMPOUNDS AS KINASE INHIBITORS FOR THE TREATMENT OF CANCER Abbott Laboratories (US) 2004-10-06 EP disclosed
US-6756378-B2 BENZYL -UREA, -THIOUREA, OR -GUANIDINE DERIVATIVES THAT INHIBIT THE BINDING OF LIGANDS TO ALPHA 4 BETA 1 INTEGRIN (VLA-4) PHARMACOPEIA DRUG DISCOVERY, INC. 2004-06-29 US disclosed
US-6696500-B2 BIOACTIVE SUBSTANCE HAVING ACIDIC GROUP AND A BIODEGRADABLE POLYMER HAVING AN OPTIONALLY PROTECTED BASIC GROUP, SUCH AS A POLYLACTONE THAT HAS BEEN ESTERIFIED, AMIDATED, OR THIOESTERIFIED WITH A COMPOUND HAVING CYCLIC AMINO GROUPS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2004-02-24 US disclosed
EP-0815853-B1 Sustained-release preparation for bioactive substance having an acidic group TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2004-01-21 EP disclosed
EP-0779281-A1 ISOXAZOLES SANKYO COMPANY LIMITED (JP) 1997-06-18 EP disclosed
US-5599587-A Phosphoric acid esters and their use in the preparation of biocompatible surfaces BIOCOMPATIBLES LIMITED (GB) 1997-02-04 US disclosed
EP-0426804-B1 2-(2-HYDROXY-3-PHENOXYPROPYLAMINO)-ETHOXYBENZENE DERIVATIVES ICI PLC (GB) 1994-01-19 EP disclosed
EP-0427480-B1 2-Hydroxy-3-phenoxypropylamino compounds ICI PLC (GB) 1994-01-12 EP disclosed
EP-0565317-A1 (2-(2-hydroxy-2 phenylethylamino)ethoxy) phenyl derivatives, processes and intermediates for their preparation, pharmaceutical compositions containing them and their use as Beta-3-adrenoceptor agonists ZENECA LIMITED (GB) 1993-10-13 EP disclosed
US-5187190-A PHENOXYPROPANOLAMINE COMPOUNDS IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1993-02-16 US disclosed
EP-0427480-A1 2-Hydroxy-3-phenoxypropylamino compounds IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1991-05-15 EP disclosed
EP-0426804-A1 2-(2-HYDROXY-3-PHENOXYPROPYLAMINO)-ETHOXYBENZENE DERIVATIVES. ICI PLC (GB) 1991-05-15 EP disclosed
WO-1990013535-A1 COMPOUNDS IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1990-11-15 WO disclosed